Trial intelligence / Profile preview

Calcitonin Prophylaxis in Phantom Limb Pain

2008-005470-12Phase 4Terminated

Sponsor
Medical University of Vienna
Start
Apr 2009
Modality
Small Molecules, Recombinant Proteins and Enzymes, Peptides
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of TBRIA in phantom limb pain (PLP) (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Phantom limb pain occurrence at day 28. Started Apr 2009; status: terminated.

02

Drugs

TBRIA
03

Conditions

phantom limb pain (PLP)

Beyond the preview

Go deeper on 2008-005470-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-005470-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call